Use of a 40 mg dose of enoxaparin Sodium as minimum to treat a patient of 65 years or older with acute ischemic stroke or an average score of 10 or higher in the scale of NIH PFor The Stroke.Methods for treating acute ischemic stroke in a patient in need thereof comprising administering...
Randomisation is stratified for maternal thrombophilia status and women are randomly assigned to ‘standard high risk care’ or ‘standard high risk care’ plus enoxaparin 40 mg from recruitment until 36+0 weeks or delivery, whichever occurs sooner. Standard high risk care includes the use of ...
We tried to identify mechanisms by which sepsis-induced pathophysiological changes may influence the effectiveness of subcutaneously (SC) administered enoxaparin 40 mg once daily. A total of 16 patients (8 men, 8 women; age 35-83 years) meeting the inclusion criteria of severe sepsis were ...
The live birth rate was 76.67% in enoxaparin 40 mg group and 70% in enoxaparin 20 mg group (p value = 0.559). There were no significant differences between both groups with respect to neonatal outcome, obstetric and maternal complications during pregnancy or puerperium. No cases of severe ...
Enoxaparin enhances AAT inhibition of TMPRSS2 activity. To determine the effects of UFH, enoxa- parin, or nadroparin, the cells were left untreated or pre-incubated for 30 min with AAT alone at 1 and 3 mg/ mL, or with combined 3 mg/mL AAT with two different concentrations ...
Methods An acute phase model, using decision analysis, and a long-term simulation Markov model were developed to compare the clinical outcomes, utilities, and direct medical costs of dabigatran 220 mg once daily and subcutaneous enoxaparin 40 mg once daily for VTE prophylaxis after TKR or THR. ...
enoxaparin 1 hour before surgery may be associated with a higher rate of major bleed.A dosage of 40 mg enoxaparin BD instead of 30 mg BD reduces VTE risk but increases bleeding risk.After discharge, a lower dosage of enoxaparin 50 mg OD is as effective at VTE prophylaxis as 90 mg OD.do...
Enoxaparin, 40 mg once daily, is as safe and effective as unfractionated heparin three times daily in preventing venous thromboembolism in patients undergoing major elective surgery for abdominal or pelvic malignancy. Enoxacan,D Bergqvist - 《British Journal of Surgery》 被引量: 363发表: 1997年 A...
Between 4% and 12% of patients undergoing colorectal surgery and receiving enoxaparin, 40 mg per day, have a postoperative VTE event. An improved understanding of why "breakthrough" VTE events occur despite guideline-compliant prophylaxis is an important patient safety question. To determine the ...
Enoxaparin was administered (40 mg subcutaneous (SC) if BMI ≤50 kg/m2 or 60 mg SC if BMI >50 kg/m2) for prevention of venous thromboembolism every 12 h starting after induction of anesthesia until discharge. Plasma anti-factor Xa activity was assessed over 12 h after the ...